Soleno Therapeutics Inc (SLNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Sales | 242 | 247 | 97 | 22 | 0 |
| Cost of Goods | 257 | 56 | 22 | 18 | N/A |
| Gross Profit | -15 | 191 | 75 | 4 | N/A |
| Operating Expenses | 3,748 | 3,430 | 3,141 | 2,448 | 1,846 |
| Operating Income | -3,507 | -3,183 | -3,044 | -2,426 | -1,846 |
| Interest Expense | 0 | 0 | 0 | 1 | 2,320 |
| Other Income | 661 | -110 | 4,925 | -9,224 | -3,052 |
| Pre-tax Income | -2,846 | -3,293 | 1,881 | -11,651 | -7,218 |
| Net Income Continuous | -2,846 | -3,293 | 1,881 | -11,651 | -7,218 |
| Net Income | $-2,846 | $-3,293 | $1,881 | $-11,651 | $-7,218 |
| EPS Basic Total Ops | 4.50 | -24.74 | 18.74 | -125.19 | 61.47 |
| EPS Basic Continuous Ops | 4.71 | -24.59 | 18.76 | -125.40 | 60.77 |
| EPS Diluted Total Ops | 4.50 | -24.74 | 18.74 | -125.19 | 61.47 |
| EPS Diluted Continuous Ops | 4.99 | -24.59 | 18.48 | -125.40 | 60.77 |
| EBITDA(a) | $-3,458 | $-3,155 | $-3,028 | $-2,411 | $-1,837 |